Table 1 Comparison of general characteristics and laboratory tests of different diameter groups
From: The surgical outcomes and risk factors of giant hepatic haemangiomas: a single centre experience
Demographics/characteristics | GH group (n = 241) | EH group (n = 132) | P-value | |
|---|---|---|---|---|
Sex (male/female) | 81/160 | 45/87 | 0.984 | |
Median age | 46 | 45 | ||
Reason for evaluation | ||||
Symptomatic | 59 (24.5%) | 37 (28.0%) | ||
Upper abdominal discomfort | 29 | 14 | ||
Indigestion | 7 | 3 | ||
Right or left quadrant pain | 22 | 17 | ||
Abdominal mass | 1 | 3 | ||
Rapid growth | 182 (75.5%) | 95 (72.0%) | ||
ASA grading | 1.45 + 0.49 | 1.47 + 0.51 | 0.317 | |
Preoperative lab tests | Normal range | |||
Leukocyte (× 109/L) | 4.0–10.0 | 5.2 ± 1.1 | 5.0 ± 0.8 | 0.065 |
Leukopenia | 11 (4.5%) | 14 (10.6%) | 0.043 | |
Hemoglobin (g/L) | Female 115–150 Male 120–155 | 130.24 ± 15.2 | 127.17 ± 16.97 | 0.195 |
Anemia | 38 (15.8%) | 35 (26.5%) | 0.018 | |
Thrombocyte (× 109/L) | 110–320 | 202.56 ± 59.06 | 183.77 ± 50.64 | 0.550 |
Thrombocytopenia | 15 (6.2%) | 18 (13.6%) | 0.026 | |
Pancytopenia cases | 1 (0.4%) | 2 (1.5%) | 0.590 | |
ALT (U/L) | 0–40 | 31.23 ± 38.40 | 27.76 ± 36.09 | 0.679 |
Increased ALT cases | 48 (19.9%) | 20 (15.15%) | 0.317 | |
AST (U/L) | 0–42 | 28.01 ± 49.37 | 24.52 ± 38.68 | 0.194 |
Increased AST cases | 19 (7.8%) | 13 (9.8%) | 0.649 | |
ALB (g /L) | 0–52 | 43.41 ± 3.07 | 43.61 ± 3.55 | 0.216 |
Total bilirubin (mmol/L) | 5.0–21.0 | 12.31 ± 4.43 | 14.29 ± 5.13 | 0.102 |
Hyperbilirubinemia cases | 10 (4.14%) | 17 (12.8%) | 0.003 | |
PT (s) | 10–13 | 11.27 ± 0.75 | 11.54 ± 0.83 | 0.067 |
High prothrombin time cases | 1 (0.4%) | 6 (4.5%) | 0.019 | |